vs
Astrana Health, Inc.（ASTH）与F5, Inc.（FFIV）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是F5, Inc.的1.2倍（$950.5M vs $822.5M），F5, Inc.净利率更高（21.9% vs 0.7%，领先21.2%），Astrana Health, Inc.同比增速更快（42.9% vs 7.3%），F5, Inc.自由现金流更多（$149.5M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 9.9%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
F5, Inc.是一家美国科技企业，专注于应用安全、多云管理、线上反欺诈、应用交付网络（ADN）相关业务，同时提供应用可用性与性能优化、网络安全、访问授权管理等产品及解决方案，助力各行业客户保障数字化业务稳定运营，提升运行效率。
ASTH vs FFIV — 直观对比
营收规模更大
ASTH
是对方的1.2倍
$822.5M
营收增速更快
ASTH
高出35.6%
7.3%
净利率更高
FFIV
高出21.2%
0.7%
自由现金流更多
FFIV
多$155.4M
$-6.0M
两年增速更快
ASTH
近两年复合增速
9.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $822.5M |
| 净利润 | $6.6M | $180.1M |
| 毛利率 | — | 81.5% |
| 营业利润率 | 1.9% | 26.0% |
| 净利率 | 0.7% | 21.9% |
| 营收同比 | 42.9% | 7.3% |
| 净利润同比 | 184.4% | 8.2% |
| 每股收益（稀释后） | $0.12 | $3.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHFFIV
| Q4 25 | $950.5M | $822.5M | ||
| Q3 25 | $956.0M | $810.1M | ||
| Q2 25 | $654.8M | $780.4M | ||
| Q1 25 | $620.4M | $731.1M | ||
| Q4 24 | $665.2M | $766.5M | ||
| Q3 24 | $478.7M | $746.7M | ||
| Q2 24 | $486.3M | $695.5M | ||
| Q1 24 | $404.4M | $681.4M |
净利润ASTHFFIV
| Q4 25 | $6.6M | $180.1M | ||
| Q3 25 | $373.0K | $190.5M | ||
| Q2 25 | $9.4M | $189.9M | ||
| Q1 25 | $6.7M | $145.5M | ||
| Q4 24 | $-7.8M | $166.4M | ||
| Q3 24 | $16.1M | $165.3M | ||
| Q2 24 | $19.2M | $144.1M | ||
| Q1 24 | $14.8M | $119.0M |
毛利率ASTHFFIV
| Q4 25 | — | 81.5% | ||
| Q3 25 | — | 82.2% | ||
| Q2 25 | — | 81.0% | ||
| Q1 25 | — | 80.7% | ||
| Q4 24 | — | 81.7% | ||
| Q3 24 | — | 80.8% | ||
| Q2 24 | — | 80.4% | ||
| Q1 24 | — | 79.3% |
营业利润率ASTHFFIV
| Q4 25 | 1.9% | 26.0% | ||
| Q3 25 | 2.0% | 25.4% | ||
| Q2 25 | 3.1% | 25.2% | ||
| Q1 25 | 3.3% | 21.7% | ||
| Q4 24 | 0.1% | 26.8% | ||
| Q3 24 | 5.9% | 25.6% | ||
| Q2 24 | 6.2% | 23.4% | ||
| Q1 24 | 7.5% | 20.5% |
净利率ASTHFFIV
| Q4 25 | 0.7% | 21.9% | ||
| Q3 25 | 0.0% | 23.5% | ||
| Q2 25 | 1.4% | 24.3% | ||
| Q1 25 | 1.1% | 19.9% | ||
| Q4 24 | -1.2% | 21.7% | ||
| Q3 24 | 3.4% | 22.1% | ||
| Q2 24 | 3.9% | 20.7% | ||
| Q1 24 | 3.7% | 17.5% |
每股收益（稀释后）ASTHFFIV
| Q4 25 | $0.12 | $3.10 | ||
| Q3 25 | $0.01 | $3.25 | ||
| Q2 25 | $0.19 | $3.25 | ||
| Q1 25 | $0.14 | $2.48 | ||
| Q4 24 | $-0.14 | $2.82 | ||
| Q3 24 | $0.33 | $2.79 | ||
| Q2 24 | $0.40 | $2.44 | ||
| Q1 24 | $0.31 | $2.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $1.2B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $3.5B |
| 总资产 | $2.2B | $6.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHFFIV
| Q4 25 | $429.5M | $1.2B | ||
| Q3 25 | $463.4M | $1.3B | ||
| Q2 25 | $342.1M | $1.4B | ||
| Q1 25 | $260.9M | $1.3B | ||
| Q4 24 | $290.8M | $1.2B | ||
| Q3 24 | $350.3M | $1.1B | ||
| Q2 24 | $327.7M | $935.6M | ||
| Q1 24 | $337.3M | $903.5M |
股东权益ASTHFFIV
| Q4 25 | $779.3M | $3.5B | ||
| Q3 25 | $775.5M | $3.6B | ||
| Q2 25 | $765.5M | $3.5B | ||
| Q1 25 | $745.4M | $3.3B | ||
| Q4 24 | $712.7M | $3.2B | ||
| Q3 24 | $704.6M | $3.1B | ||
| Q2 24 | $678.9M | $3.0B | ||
| Q1 24 | $653.5M | $2.9B |
总资产ASTHFFIV
| Q4 25 | $2.2B | $6.3B | ||
| Q3 25 | $2.2B | $6.3B | ||
| Q2 25 | $1.4B | $6.1B | ||
| Q1 25 | $1.3B | $5.9B | ||
| Q4 24 | $1.4B | $5.9B | ||
| Q3 24 | $1.3B | $5.6B | ||
| Q2 24 | $1.3B | $5.4B | ||
| Q1 24 | $1.2B | $5.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $159.2M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $149.5M |
| 自由现金流率自由现金流/营收 | -0.6% | 18.2% |
| 资本支出强度资本支出/营收 | 0.3% | 1.2% |
| 现金转化率经营现金流/净利润 | -0.44× | 0.88× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $861.2M |
8季度趋势，按日历期对齐
经营现金流ASTHFFIV
| Q4 25 | $-2.9M | $159.2M | ||
| Q3 25 | $10.0M | $208.1M | ||
| Q2 25 | $90.9M | $282.2M | ||
| Q1 25 | $16.6M | $256.6M | ||
| Q4 24 | $-10.9M | $202.8M | ||
| Q3 24 | $34.0M | $246.5M | ||
| Q2 24 | $23.2M | $159.0M | ||
| Q1 24 | $6.0M | $221.6M |
自由现金流ASTHFFIV
| Q4 25 | $-6.0M | $149.5M | ||
| Q3 25 | $7.4M | $191.9M | ||
| Q2 25 | $89.5M | $273.7M | ||
| Q1 25 | $13.6M | $246.1M | ||
| Q4 24 | $-13.5M | $194.7M | ||
| Q3 24 | $31.7M | $240.4M | ||
| Q2 24 | $20.4M | $153.1M | ||
| Q1 24 | $5.6M | $212.2M |
自由现金流率ASTHFFIV
| Q4 25 | -0.6% | 18.2% | ||
| Q3 25 | 0.8% | 23.7% | ||
| Q2 25 | 13.7% | 35.1% | ||
| Q1 25 | 2.2% | 33.7% | ||
| Q4 24 | -2.0% | 25.4% | ||
| Q3 24 | 6.6% | 32.2% | ||
| Q2 24 | 4.2% | 22.0% | ||
| Q1 24 | 1.4% | 31.1% |
资本支出强度ASTHFFIV
| Q4 25 | 0.3% | 1.2% | ||
| Q3 25 | 0.3% | 2.0% | ||
| Q2 25 | 0.2% | 1.1% | ||
| Q1 25 | 0.5% | 1.4% | ||
| Q4 24 | 0.4% | 1.1% | ||
| Q3 24 | 0.5% | 0.8% | ||
| Q2 24 | 0.6% | 0.8% | ||
| Q1 24 | 0.1% | 1.4% |
现金转化率ASTHFFIV
| Q4 25 | -0.44× | 0.88× | ||
| Q3 25 | 26.69× | 1.09× | ||
| Q2 25 | 9.65× | 1.49× | ||
| Q1 25 | 2.48× | 1.76× | ||
| Q4 24 | — | 1.22× | ||
| Q3 24 | 2.11× | 1.49× | ||
| Q2 24 | 1.21× | 1.10× | ||
| Q1 24 | 0.40× | 1.86× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
FFIV
| Services | $412.2M | 50% |
| Products | $410.3M | 50% |
